XML 45 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment

Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the three-month periods ended March 31, 2023 and 2022, were as follows (in thousands):

    

Three Months Ended

    

March 31, 

    

2023

    

2022

Net sales

 

  

 

  

Cardiovascular

$

287,976

$

266,936

Endoscopy

 

9,589

 

8,479

Total net sales

 

297,565

 

275,415

Income from operations

 

  

 

  

Cardiovascular

 

23,934

 

13,126

Endoscopy

 

2,449

 

2,107

Total income from operations

 

26,383

 

15,233

Total other expense — net

 

(883)

 

(1,062)

Income tax expense

 

4,797

 

3,626

Net income

$

20,703

$

10,545